Lv1
78 积分 2024-02-05 加入
Pharmacokinetics, pharmacodynamics and safety profile of SKB336, a selective inhibitor of coagulation factor XI/XIa in healthy subjects
6天前
已完结
New therapies to treat cardiac amyloidosis
17天前
已完结
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
1个月前
已完结
Differential Effects of Volanesorsen on ApoC-III, Triglycerides and Pancreatitis in Familial Chylomicronemia Syndrome Diagnosed by Genetic or Non-Genetic Criteria
2个月前
已完结
Differential Effects of Volanesorsen on ApoC-III, Triglycerides and Pancreatitis in Familial Chylomicronemia Syndrome Diagnosed by Genetic or Non-Genetic Criteria
2个月前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
3个月前
已完结
APOC3 siRNA and ASO therapy for dyslipidemia
3个月前
已完结
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk
3个月前
已完结
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk
3个月前
已关闭
Remnant cholesterol as a residual risk in atherosclerotic cardiovascular disease patients under statin-based lipid-lowering therapy : A Post Hoc Analysis of the RACING trial
4个月前
已完结
皖公网安备34019202002308
